Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range SpaceX Scrubs Starship V3 Test Flight Reschedules for Friday IPO Filing Reveals 15 Billion Program Cost Fed Chair Powell Vows Not to Be Shadow Chair as Historic Overlap with Incoming Chair Warsh Approaches Amazon Reports Record Sales During Thanksgiving Holiday Week Fed Holds Firm on Rates as Jobs Data Dims Cut Hopes Definitive Healthcare Corp DH Q1 2026 Earnings EPS Surge Beats Expectations Stock Climbs BY Q1 2026 Earnings EPS Beats Estimates by 755 Stock Slightly Down VRNS Q1 2026 Earnings Earnings Surprise Overshadows Missing Revenue Detail Gladstone Investment Corporation Q1 2026 Earnings Mixed Quarter as EPS Misses Estimates Notes Edge Higher TEM Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise FMS Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Morgan Stanley Emerging Markets Debt Fund MSD Holds Steady Near 735 Consolidating Within a Range New Providence Acquisition Corp III Warrants NPACW Edges Higher as Warrants Test Key Resistance NioCorp Developments Ltd Warrant NIOBW Surges 117 Testing Key Resistance at 201 Classover Holdings KIDZ Surges 247 Key Levels to Watch After Breakout Renasant Corporation RNST Holds Near 41 as Consolidation Persists Meta Tests AI Subscription Plans Starting at 799 Monthly Signaling New Revenue Stream Jim Cramers Take on Home Depot Housing Market Trends and Interest Rates May Shape HD Stock Performance Geosphere Capitals Arvind Sanger Cautiously Optimistic on Indian Markets Eyes Earnings Revival Wells Fargo Upgrades Automatic Data Processing ADP to Equal Weight Sets 214 Target SpaceX Relies Heavily on Starlink for Growth as Nasdaq IPO Approaches Bahrain Minister Calls UKGulf Trade Deal a Monumental Achievement Potential Economic Boost Ahead CoveredCall ETF MSTY Limited Upside Potential Full Downside Exposure Super League Enterprise Inc SLE Q1 2026 Earnings NarrowerThanExpected Loss Amidst Stock Decline Allarity Therapeutics ALLR Hovers Near Support as Mild Pullback Tests Key Levels